Mice given a relatively new cancer drug can survive an otherwise lethal dose of vaccinia virus, a relative of smallpox virus, report scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The findings, say the investigators, suggest that Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine. The classic smallpox vaccine is made from live, weakened vaccinia virus and is not recommended for people with compromised immunity, except in emergency situations where they may have been exposed to smallpox virus.
"This study helps illuminate the cellular machinery used by poxviruses to exit infected cells, and also provides new support for the concept of treating viral infections by targeting specific host cell molecules rather than the viruses themselves," says NIAID Director Anthony S. Fauci, M.D.
The senior author of the paper, published online this week in the journal Nature Medicine, is Daniel Kalman, Ph.D., of Emory University School of Medicine in Atlanta.
Like all viruses, poxviruses co-opt various cellular molecules and processes to enter a cell, replicate and then spread to uninfected cells. Using lab-grown cells, Dr. Kalman and his colleagues identified specific cell proteins vaccinia uses to detach from an infected cell and move toward an uninfected cell. The proteins, members of the Abl-family (pronounced "able") of tyrosine kinases, are well known to cancer investigators because mutation of one family member, Abl, causes a rare form of cancer known as chronic myelogenous leukemia (CML). Gleevec inhibits Abl-family tyrosine kinases and has proved very useful in treating CML.
To learn whether Gleevec could prevent or lessen vaccinia's ability to spread in a living organism, the researchers treated mice with either saline solution or with Gleevec at a dose equivalent to that given to humans being treated for CML. NePage: 1 2 3 Related biology news :1
. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer2
. Jump-starting T Cells In Skin Cancer3
. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer4
. Fox Chase Cancer Center scientists identify immune-system mutation5
. Breakthrough Microarray-based Technology for the Study of Cancer6
. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene7
. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery8
. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers9
. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer10
. New Breast Cancer Test Could Save Lives11
. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells